Menu

Recent Interviews

Ryan Jackson, CEO, Newlox Gold Ventures Corp.

Ryan Jackson
CEO | Newlox Gold Ventures Corp.
60 Laurie Crescent, V7S 1B7 West Vancouver (CAN)

info@newloxgold.com

+1 778 738 0546

Newlox CEO Ryan Jackson on building a green gold producer with a rapid growth trajectory


Nick Mather, CEO, SolGold PLC

Nick Mather
CEO | SolGold PLC
1 King Street, EC2V 8AU London (GB)

emichael@solgold.com.au

+44 20 3823 2125

SolGold CEO Nick Mather on building a major gold and copper mining company


Jared Scharf, CEO, Desert Gold Ventures Inc.

Jared Scharf
CEO | Desert Gold Ventures Inc.
4770 72nd St,, V4K 3N3 Delta (CAN)

jared.scharf@desertgold.ca

Desert Gold Ventures CEO Jared Scharf on West Africa and its potential


16. January 2020 | 11:53 CET

Aurora Cannabis, Canopy Growth, EXMceuticals - Profits with turnaround

  • Cannabis
Photo credits: pixabay.com

2019 was not a good year for investors in the cannabis sector with a long-term approach. After a never-ending rally in the years before, the party was over. However, the price capers can also be an opportunity to enter companies that are now one experience richer than they were a year ago in a champagne mood.

time to read: 1 minutes by Mario Hose


Jonathan Summers, CEO, EXMceuticals Inc.
"[...] In being able to grow in some of the best natural conditions in the world along the equator, Africa offers enormous advantages for cannabis cultivation. [...]" Jonathan Summers, CEO, EXMceuticals Inc.

Full interview

 

Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author


Share price recovery has begun

The shares of Aurora Cannabis changed hands in March 2019 in the peak at 13.67 CAD - the year before the historic high was even 16.24 CAD. What then followed was a flawless trend towards CAD 0.00, which ended last week at a low of CAD 1.96.

On yesterday's trading day, the share was traded at the closing price of 2.68 CAD. A return of over 36% within one week would have been theoretically possible. The market value of Aurora Cannabis is currently CAD 2.93 billion.

Clearly caught up from the low

With yesterday's closing price of 32.46 CAD and a current market value of 11.31 billion CAD, Canopy Growth is one of the top companies in the cannabis industry. In 2018 the shares changed hands at a peak of 76.68 CAD and last year the peak was 70.99 CAD.

The rapid price losses in phases ended in November at 18.23 CAD. Since then the share price has regained ground and hypothetically a performance of over 78% would have been possible from the low until yesterday.

Starting point for turnaround

For a long time, the stock of the newcomer EXMceuticals was excluded from the price capers of the well-known names. Although the share price was volatile, it nevertheless moved sideways between 0.87 CAD and 1.72 CAD. But in November 2019 the share price dropped further and was traded at CAD 0.45 at the beginning of 2020.

It now looks like it has bottomed out and could become the starting point for a turnaround. At yesterday's closing price of CAD 0.50, the company has a market value of CAD 18.28 million. The company yesterday announced further details of its development, it is continuing to make progress operationally.


Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

15. July 2020 | 12:23 CET | by Mario Hose

BioNTech, EXMceuticals, XPhyto - Covid-19 and legalizations offer potential

  • Cannabis

In recent months, the society around the globe has been going through a process of change of deceleration and standstill. Priorities have been redefined and implemented at record speeds in many places. Covid-19 serves as a catalyst for change for many people. The reasons can be different. The development of corona vaccines and antibody tests will make a lot of money in the future and the legalization of cannabis in the USA on a federal level has the potential to create a renaissance.

Read

19. May 2020 | 15:02 CET | by Mario Hose

Aphria, Aurora Cannabis, Canopy Growth, EXMceuticals - do not miss the entry!

  • Cannabis

The nationwide and anonymous advertising format of Deutsche Post is called POSTAKTUELL and is published regularly in large print runs. The stack of advertising is wrapped in a foil and the practical added value for the recipient is the TV guide. The front of POSTAKTUELL is particularly eye-catching and anyone who advertises there will reach a lot of people. In the meantime, advertising for products and applications with active ingredients from the cannabis plant is already being done there. CBD reaches the general public and despite the Corona Pandemic, the industry's stocks are running in turnaround mode and have left the lows.

Read

23. March 2020 | 15:00 CET | by Mario Hose

Aurora Cannabis, Bayer, EXMceuticals - ready for the time after Corona

  • Cannabis

The cannabis hype was over and then came the corona crisis. Investors who believed in the active ingredient of cannabis and put money into the shares of companies in this industry are now likely to be sitting on a huge loss in most cases. It all started with the idea of a few companies to make one of the oldest medicinal plants in the world acceptable for general use within the framework of legalization. However, high margins and a large market soon led to competition and a brokerage industry was earning a lot of money - soon several hundred cannabis companies were listed on the stock exchange.

Read